Bepridil versus verapamil in stable angina pectoris — a controlled clinical trial
Authors:
- 1 June 1989
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 23 (3) , 357-364
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Pharmacokinetics and metabolism of bepridilThe American Journal of Cardiology, 1985
- Effect of bepridil in patients with chronic stable angina: results of a multicenter trial.Circulation, 1985
- Bepridil for chronic stable angina pectoris: Results of a prospective multicenter, placebo-controlled, dose-ranging study in 77 patientsThe American Journal of Cardiology, 1984
- Evaluation of bepridil, a new antianginal agent: Clinical and hemodynamic alterations during the treatment of stable angina pectorisThe American Journal of Cardiology, 1984
- Profile of Coronary Vasodilator and Cardiac Actions of Bepridil Revealed by Use of Isolated, Blood-Perfused Heart Preparations of the DogJournal of Cardiovascular Pharmacology, 1983
- Effects of Bepridil, a New Antianginal Agent, on Ambulatory Electrocardiography in Human VolunteersJournal of Cardiovascular Pharmacology, 1983
- Nifedipine, diltiazem, bepridil and verapamil uptakes into cardiac and smooth musclesEuropean Journal of Pharmacology, 1983
- Uptake of bepridil into isolated ventricular myocytesBiochemical Pharmacology, 1983
- THE BENEFICIAL ACTIONS OF BEPRIDIL IN ACUTE MYOCARDIAL INFARCTION IN ANAESTHETIZED DOGSBritish Journal of Pharmacology, 1981
- Antidysrhythmic and Electrophysiological Effects of a New Antianginal Agent, BepridilJournal of Cardiovascular Pharmacology, 1980